Duloxetine-induced hypomania: Case report and brief review of the literature on SNRIs-induced mood switching

Journal of Psychopharmacology

Volumn 23, Issue 5, 2009, Pages 592-596

  Peritogiannis, V ^a,c   Antoniou, K ^b   Mouka, V ^a,b   Mavreas, V ^b   Hyphantis, T N ^a  

^a Mobile Psychiatric Unit of the Prefectures of Ioannina and Thesprotia   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c Society for the Promotion of Mental Health in Epirus   (Greece)

Author keywords

Duloxetine; Hypomania; Mania; Serotonin noradrenaline reuptake inhibitors; Switching; Venlafaxine

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DULOXETINE; MIRTAZAPINE; NEUROLEPTIC AGENT; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRIFLUOPERAZINE;

ADULT; AGGRESSION; ANXIETY DISORDER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DEPRESSIVE PSYCHOSIS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERACTIVITY; HYPOMANIA; INSOMNIA; IRRITABILITY; MOOD CHANGE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; SIDE EFFECT; TREATMENT OUTCOME;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 67449133561     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108089841     Document Type: Article

References (39)

1. Abdelmawla A., Langley R., Szabadi E., Bradshaw C., (1999) Comparison of the effects of venlafaxine, desipramine and paroxetine on noradrenaline and methoxamine evoked constriction of the dorsal hand vein. Br J Clin Pharmacol 48: 345-354. (Pubitemid 29417717)
2. Akiskal H., (2005) The dark side of bipolarity: detecting bipolar depression in its pleomorphic expressions. J Affect Disord 84: 107-115. (Pubitemid 40227436)
3. Ali S., Milev R., (2003) Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature. Can J Psychiatry 48: 258-264. (Pubitemid 36740440)
4. Andrade C., (2004) Antidepressant-withdrawal mania: a critical review and synthesis of the literature. J Clin Psychiatry 65: 987 - 993.
5. Bymaster F., Dreshfield-Ahmad L., Threlkeld P., Shaw J., Thompson L., Nelson D., (2001) Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptors subtypes, and other neuronal receptors. Neuropsychopharmacology 25: 871-880. (Pubitemid 34031892)
6. Chand P., Kalyani G., Murthy P., (2004) Venlafaxine-associated hypomania in unipolar depression. Can J Psychiatry 49: 496. (Pubitemid 39071374)
7. Chun B., Dunner D., (2004) Areview of antidepressant-induced hypomania in major depression: suggestions for DSM-V. Bipolar Disord 6: 32-42. (Pubitemid 38256502)
8. de Dios C., Ezquiaga E., (2007) Manic switching in patients receiving duloxetine. Am J Psychiatry 164: 1121. (Pubitemid 47121408)
9. Desarkar P., Bakhla A., Sihna VK., (2007) Duloxetine-induced ultrarapid cycling in an adolescent with bipolar depression. J Clin Psychopharmacol 27: 115-116. (Pubitemid 46105790)
10. Dunner D., D™Souza D., Kajdask D., Detke M., Russell J., (2005) Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression. J Affect Disord 87: 115-119. (Pubitemid 40828210)
11. Fava G., Mangelli L., (2003) Mania associated with venlafaxine discontinuation. Int J Neuropsychopharm 6: 89-90. (Pubitemid 36373104)
12. Gupta N., (2001) Venlafaxine-induced hypomanic switch in bipolar depression. Can J Psychiatry 46: 760-761. (Pubitemid 33127093)
13. Holliday S., Benfield P., (1995) Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs 49: 280-294.
14. Khazaal Y., (2007) Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder. Ann Pharmacother 41: 359 - 360. (Pubitemid 46340071)
15. Kline NS., (1958) Clinical experience with iproniazid (marsilid). J Clin Exp Psychopathol 19: 72-79.
16. Leverich G., Altshuler L., Frye M., Suppes T., McElroy S., Keck P., (2006) Risk of mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bubropion as adjuncts to mood stabilizers. Am J Psychiatry 163: 232-239. (Pubitemid 44480842)
17. Liau C., Shen W., Su K., (2006) Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressed patient. Psychiatry Clin Neurosci 60: 121-122.
18. Liberek C., Aubry JM., Baud P., (2006) Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association. Therapie 61: 531-533. (Pubitemid 350188053)
19. Lim CJ., Leckman JF., Young C., Martin A., (2005) Antidepressant-induced manic conversion: a developmentally informed synthesis of the literature. Int Rev Neurobiol 65: 25-52.
20. Montgomery S., Prost J., Solles A., Briley M., (1996) Efficacy and tolerability of milnacipran: an overview. Int Clin Psychopharmacol 11 (Suppl. 4). 47-51. (Pubitemid 26371018)
21. Morishita S., Arita S., (2004) Prevalence of induced mania in patients treated with milnacipran: a comparison with paroxetine. Eur Psychiatry 19: 315-316. (Pubitemid 38987846)
22. Nemeroff C., Evans D., Gyulai L., Sachs G., Bowden C., Gergel I., (2001) Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 158: 906-912. (Pubitemid 32547620)
23. Papakostas G., Thase M., Fava M., Nelson J., Shelton R., (2007) Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiatry 62: 1217-1227. (Pubitemid 350060895)
24. Pirraglia P., Stafford R., Singer D., (2003) Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. J Clin Psychiatry 5: 153-157.
25. Post RM., Altshuler LL., Leverich GS., Frye MA., Nolen WA., Kupka RW., (2006) Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 189: 124-131. (Pubitemid 44231270)
26. Pritchett Y., Marciniak M., Corey-Lisle P., Berzon R., Desaiah D., Detke M., (2007) Use of effect size to determine the optimal dose of duloxetine in major depressive disorder. J Psychiatr Pract 41: 311-318. (Pubitemid 44854996)
27. Rudolph R., Derivan A., (1996) The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. J Clin Psychopharmacol 16 (Suppl. 2). 54-61.
28. Sachs GS., Lafer B., Stoll AL., Banov M., Thibault AB., Tohen M., (1994) A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 55: 391-393. (Pubitemid 24337995)
29. Schatzberg A., (2003) Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. J Clin Psychiatry 64 (Suppl.). 30-37. (Pubitemid 37267813)
30. Shulman R., Scheftner W., Nayudu S., (2001) Venlafaxine-associated mania. J Clin Psychopharmacol 21: 239-241. (Pubitemid 32221065)
31. Smith D., Dempster C., Glanville J., Freemantle N., Anderson I., (2002) Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry 180: 394-404.
32. Stoner S., Williams R., Worrel J., Ramlatchman L., (1999) Possible venlafaxine-induced mania. J Clin Psychopharmacol 19: 184-185. (Pubitemid 29161966)
33. Thase M., Entsuah R., Rudolph R., (2001) Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178: 234-241. (Pubitemid 32183606)
34. Tran P., Bymaster F., McNamara R., Potter W., (2003) Dual monoamine modulation for improved treatment of major depressive disorder. J Clin Psychopharmacol 23: 78-86. (Pubitemid 36164428)
35. Vieta E., Martinez-Aran A., Goikolea JM., Torrent C., Colom F., Benabarre A., (2002) A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 63: 508-512. (Pubitemid 34680359)
36. Viktrup L., Perahia D., Tylee A., (2004) Duloxetine treatment of stress urinary incontinence in women does not induce mania or hypomania. Prim Care Companion J Clin Psychiatry 6: 239-243.
37. Wehr TA., Goodwin FK., (1987) Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144: 1403-1411. (Pubitemid 18009530)
38. Wilson R., Jenkins P., (1997) Suspected complication of treatment with venlafaxine. J Clin Psychopharmacol 17: 323. (Pubitemid 27312434)
39. Yuksel F., Basterzi A., Goka E., (2004) Venlafaxine-induced mania. Can J Psychiatry 49: 786-787. (Pubitemid 40094956)